Cargando…
Serum EGF-receptor and HER-2 extracellular domains and prognosis of non-small-cell lung cancer
This retrospective study aimed at evaluating the prognostic impact of high serum levels of either the HER-2 extracellular domain (ECD) or the epidermal growth factor receptor (EGFR) ECD measured using two specific ELISAs in 221 patients with non-small-cell lung cancer (NSCLC) receiving conventional...
Autores principales: | Jacot, W, Pujol, J-L, Boher, J-M, Lamy, P-J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409859/ https://www.ncbi.nlm.nih.gov/pubmed/15226769 http://dx.doi.org/10.1038/sj.bjc.6601987 |
Ejemplares similares
-
Markov model and markers of small cell lung cancer: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis
por: Boher, J-M, et al.
Publicado: (1999) -
Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors
por: Jacot, W, et al.
Publicado: (2001) -
Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients
por: Darlix, Amélie, et al.
Publicado: (2016) -
Serum HE4: An Independent Prognostic Factor in Non-Small Cell Lung Cancer
por: Lamy, Pierre-Jean, et al.
Publicado: (2015) -
Inhibition of the EGF Receptor by Binding to an Activating Kinase Domain Interface
por: Zhang, Xuewu, et al.
Publicado: (2007)